NEW YORK (GenomeWeb) – Twist Bioscience announced today that it has raised $27 million in venture financing, completing a $60 million financing it began in March.

The new funding includes a key investment from Biomatics Capital as well as new investors Reinet Fund, NFT Investment Limited, Kangmei Group, Bay City Capital GF Xinde Life Science Investment Fund, 3W Partners Capital, and Ditch Plains Capital Management.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.